Skip to main content
. 2018 Oct;7(5):599–608. doi: 10.21037/tlcr.2018.08.03

Figure 1.

Figure 1

Algorithm for management of patients with malignant peritoneal mesothelioma. CRS, cytoreductive surgery; CT, computed tomography; HIPEC, hyperthermic perioperative chemotherapy; NIPEC-LT, normothermic intraperitoneal chemotherapy long-term; MRI, magnetic resonance imaging; PET, positron emission tomography.